Neuroaetiology of chronic fatigue syndrome: An overview

World Journal of Biological Psychiatry

Volumn 9, Issue 3, 2008, Pages 165-171

  Sanders, Patricia ^a   Korf, Jakob ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Chronic fatigue syndrome; Depression; HPA axis; Inflammation; Virus infection

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTEROID;

CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; COGNITIVE THERAPY; GENETIC PREDISPOSITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHESIS; IMMUNOPATHOLOGY; OXIDATIVE STRESS; PHYSICAL DISEASE; REVIEW; VIRUS DETECTION; VIRUS INFECTION;

FATIGUE SYNDROME, CHRONIC; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; PITUITARY-ADRENAL SYSTEM; VIRUS DISEASES;

EID: 48249102602     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701310971     Document Type: Review

References (71)

1. Bell, DS (1995) Chronic fatigue syndrome in children: A review. 1, pp. 412-420.
2. Bested, AC, Saunders, PR and Logan, AC (2001) Chronic fatigue syndrome: neurological findings may be related to blood-brain barrier permeability. 57, pp. 231-237.
3. Buchwald, D., Ashly, RL, Pearlman, T., Kith, P. and Komaroff, AL (1996) Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. 50, pp. 25-30.
4. Buchwald, D., Herrell, R. Ashton, S. et al. (2001) A twin study of chronic fatigue. 63, pp. 936-943.
5. Carmel, L., Efroni, S., White, PD, Aslakson, E., Vollmer-Conna, U. and Rajeevan, MS (2006) Gene expression profile of empirically delineated classes of unexplained chronic fatigue. 7, pp. 375-386.
6. Chia, JKS (2005) The role of enterovirus in chronic fatigue syndrome. 58, pp. 1126-1132.
7. Cleare, AJ (2003) The neuroendocrinology of chronic fatigue syndrome. 24, pp. 236-252.
8. Cleare, AJ (2004) The HPA axis and the genesis of chronic fatigue syndrome. 15, pp. 55-59.
9. Cope, H. and David, AS (1996) Neuroimaging in chronic fatigue syndrome. 60, pp. 471-473.
10. Cope, H., Pernet, A., Kendall, B. and David, A. (1995) Cognitive functioning and magnetic resonance imaging in chronic fatigue. 167, pp. 86-94.
11. De Lange, FP, Kalkman, JS, Bleijenberg, G., Hagoort, P., van der Meer, JWM and Toni, I. (2005) Gray matter volume reduction in the chronic fatigue syndrome. 26, pp. 777-781.
12. Deale, A., Chalder, T., Marks, I. and Wessely, S. (1997) Cognitive behavior therapy for chronic fatigue syndrome: A randomised controlled trial. 154, pp. 408-414.
13. Demitrack, M., Dale, J. Straus, S. et al. (1991) Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. 73, pp. 1224-1234.
14. Di Giorgio, A, Hudson, M., Jerjes, W. and Cleare, AJ (2005) 24-Hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. 67, pp. 433-440.
15. Fang, H., Xie, Q., Boneva, R., Fostel, J., Perkins, R. and Tong, W. (2006) Gene expression profile exploration of a large dataset on chronic fatigue syndrome. 7, pp. 429-440.
16. Fischler, B. (1999) Review of clinical and psychobiological dimensions of the chronic fatigue syndrome: Differentiation from depression and contribution of sleep dysfunctions. 3, pp. 131-146.
17. Fostel, J., Boneva, R. and Lloyd (2006) A Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis. 7, pp. 441-454.
18. Fukuda, K., Straus, S., Hickie, I., Sharpe, M., Dobbins, J. and Komaroff, A. (1994) The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Case Definition Study Group. 121, pp. 953-959.
19. Fulcher, KY and White, PD (1997) Randomized controlled trial of graded exercise in patients with the chronic fatigue syndrome. 314, pp. 1647-1652.
20. Gaab, J., Huster, D. Peisen, R. et al. (2002) The low dose dexamethasone suppression test in chronic fatigue syndrome and health. 64, pp. 311-318.
21. Gladkevich, A., Kauffman, H. F. and Korf, J. (2004) Lymphocytes as a neural probe: Potential for studying psychiatric disorders. 28, pp. 559-576.
22. Glaser, R. and Kiecolt-Glaser, JK (1998) Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome. 105:3, pp. 35-42.
23. Glaser, R., Padgett, DA Litsky, ML et al. (2005) Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. 19, pp. 91-103.
24. Goertzel, BN, Pennachin, C., de Souza Coelho, L, Gurbaxani, B., Maloney, EM and Jones, JF (2006) Combination of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome patients. 7, pp. 475-483.
25. Goertzel, BN, Pennachin, C., de Souza Coelho, L, Maloney, EM, Jones, JF and Gurbaxani, B. (2006) Allostatic load is associated with symptoms in chronic fatigue syndrome patients. 7, pp. 485-494.
26. Gottschalk, M., Kumpfel, T. Flachenecker, P. et al. (2005) Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. 62, pp. 277-280.
27. Hampton, T. (2006) Researchers find genetic clues to chronic fatigue syndrome. 295, pp. 2466-2467.
28. Hatcher, S. and House, A. (2003) Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome. A case-control study. 33, pp. 1185-1192.
29. Hickie, I., Kirk, K. and Martin, N. (1999) Unique genetic and environmental determinants of prolonged fatigue: A twin study. 29, pp. 259-268.
30. Hotopf, M., Noah, N. and Wessely, S. (1996) Chronic fatigue and minor psychiatric morbidity after viral meningitis: A controlled study. 60, pp. 495-503.
31. Jason, LA, Richman, JA Rademaker, AW et al. (1999) A community-based study of chronic fatigue syndrome. 159, pp. 2129-2137.
32. Jason, LA, King, CP, Taylor, R. and Kennedy, C. (2000) Defining chronic fatigue syndrome: Methodological challenges. 7, pp. 17-32.
33. Jason, LA, Corradi, K., Torres-Harding, S., Taylor, RR and King, C. (2005) Chronic fatigue syndrome: The need for subtypes. 15, pp. 29-58.
34. Jerjes, WK, Cleare, AJ, Wessely, S., Wood, PJ and Taylor, NF (2005) Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. 87, pp. 299-304.
35. Jerjes, WK, Peters, TJ, Taylor, NF, Wood, PJ, Wessely, S. and Cleare, AJ (2006) Diurnal excretion of urinary cortisol, cortisone and cortisol metabolites in chronic fatigue syndrome. 60, pp. 145-153.
36. Jones, JF, Nisenbaum, R., Solomon, L., Reyes, M. and Reeves, WC (2004) Chronic fatigue syndrome and other fatiguing illnesses in adolescents: A population-based study. 35, pp. 34-40.
37. Kaiser, J. (2006) Genes and chronic fatigue: How strong us the evidence?. 312, pp. 669-670.
38. Katon, WJ, Buchwald, D., Simon, G., Russo, JE and Mease, PJ (1991) Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. 6, pp. 277-285.
39. Kennedy, W., Spence, VA, McLaren, M., Hill, A., Underwood, C. and Belch, JJF (2005) Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. 39, pp. 584-589.
40. Koelle, DM, Barcy, S. Huang, ML et al. (2000) Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome. 35, pp. 518-525.
41. Lange, G., DeLuca, J., Maldjian, JA, Lee, H., Tiersky, LA and Natelson, BH (1999) Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. 171, pp. 3-7.
42. Lloyd, A. and Klimas, N. (1994) Immunologic studies of CFS. 18, p. S160.
43. Lyall, M., Peakman, M. and Wessely, S. (2003) A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. 55, pp. 79-90.
44. Maes, M., Mihaylova, I. and de Ruyter, M. (2006) Lower serum zinc in chronic fatigue syndrome (CFS): Relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. 90, pp. 141-147.
45. Maes, M., Mihaylova, I. and Leunis, JC (2006) Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. 27, pp. 621-625.
46. Maloney, EM, Gurbaxani, BM, Jones, JF, de Souza Coelho, L, Pennachin, C. and Goertzel, BN (2006) Chronic fatigue syndrome and high allostatic load. 7, pp. 467-473.
47. Manu, P., Matthews, DA and Lane, TJ (1988) The mental health of patients with a chief complaint of chronic fatigue; a prospective evaluation and follow-up. 48, pp. 2213-2217.
48. Marshall, GS (1999) Report of a workshop on the epidemiology, natural history, and pathogenesis of chronic fatigue syndrome in adolescents. 134, pp. 395-405.
49. O'Dowd, H., Gladwell, P., Rogers, CA, Hollinghurst, S. and Gregory, A. (2006) Cognitive behavioural therapy in chronic fatigue syndrome: A randomised controlled trial of an outpatient group programme. 10:37, pp. 1-137.
50. Patarca-Montero, R., Mark, T., Fletcher, MA and Klimas, N. (2000) Immunology of chronic fatigue syndrome. 34, pp. 69-107.
51. Powell, P., Bentall, RP, Nye, FJ and Edwards, RHT (2004) Patient education to encourage graded exercise in chronic fatigue syndrome. Two year follow-up of randomised controlled trial. 184, pp. 142-146.
52. Prins, JB, Bleijenberg, G. Bazelmans, E. et al. (2001) Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised trial. 357, pp. 841-845.
53. Prins, JB, van der Meer, JW and Bleijenberg, G. (2006) Chronic fatigue syndrome. 367, pp. 346-355.
54. Ranjith, G. (2005) Epidemiology of chronic fatigue syndrome. 55, pp. 13-19.
55. Ridsdale, L., Darbishire, L. and Seed, PT (2004) Is graded exercise better than cognitive behavioural therapy for fatigue? A UK randomised trial in primary care. 34, pp. 37-49.
56. Rimes, KA and Chalder, T. (2005) Treatments for chronic fatigue syndrome. 55, pp. 32-39.
57. Sairenji, T., Yamanishi, K., Tachibana, Y., Bertoni, G. and Kurata, T. (1995) Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. 38, pp. 269-273.
58. Schwartz, RB, Garada, MB Komaroff, AL et al. (1994) Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. 162, pp. 935-941.
59. Sharpe, M., Hawton, K. Simkin, S. et al. (1996) Cognitive behaviour therapy for the chronic fatigue syndrome: A randomized controlled trial. 312, pp. 22-26.
60. Smith, AK, White, PD, Aslakson, E., Vollmer-Conna, U. and Mangalathu, S. (2006) Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained fatigue. 7, pp. 387-394.
61. Steele, L., Dobbins, JG Fukuda, K. et al. (1998) The epidemiology of chronic fatigue syndrome in San Francisco. 105, p. S83.
62. Straus, SE, Tosato, G. Armstrong, G. et al. (1985) Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. 102, pp. 7-16.
63. Strober, W. (1994) Immunological function in chronic fatigue syndrome. pp. 208-231. Marcel Dekker, New York
64. Sullivan, PF, Evengard, B., Jacks, A. and Pedersen, NL (2005) Twin analyses of chronic fatigue in a Swedish national sample. 35, pp. 1327-1336.
65. Tanaka, M. et al. (2006)
66. Thompson, LM, Rubin, RT and McCracken, JT (1992) Neuroendocrine aspects of primary endogenous depression. XII. Receiver operating characteristics and kappa analyses of serum and urine cortisol measure in patients and matched controls. 17, pp. 507-515.
67. Wessely, S. and Powell, R. (1989) Fatigue syndromes: A comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. 52, pp. 940-948.
68. Wessely, S. (1995) The epidemiology of chronic fatigue syndrome. 17, pp. 1-12.
69. Wessely, S., Hotopf, M. and Sharpe, M. (1998) pp. 1-416. Oxford University Press, Oxford
70. Wheatland, R. (2005) Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. 65, pp. 287-295.
71. Wood, CG, Bentall, RP, Gopfert, M. and Edwards, RHT (1991) A comparative assessment of patients with chronic fatigue syndrome and muscle disease. 21, pp. 619-628.